{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:26:34Z","timestamp":1768404394461,"version":"3.49.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Sickle beta+thalassemia is considered to be a mild form of sickle cell disease. However, some patients with mild disease can present with osteonecrosis. Here, we present a rare 3-year-old male who presented with acute pain, a baseline hemoglobin of 13\u2009g\/dL, who acutely developed multifocal osteonecrosis, and improved with partial exchange transfusion and hydroxyurea therapy.<\/jats:p>","DOI":"10.1097\/mph.0000000000002155","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T15:43:29Z","timestamp":1620747809000},"page":"e428-e430","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Multifocal Osteonecrosis in a 3-Year-old Child With Sickle Beta Plus Thalassemia"],"prefix":"10.1097","volume":"44","author":[{"given":"Neha","family":"Bhasin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Hematology\/Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Price","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Desoky","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, University of Arizona, Tucson, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00256-013-1803-4","article-title":"How do radiologists evaluate osteonecrosis?","volume":"43","author":"Lee","year":"2014","journal-title":"Skeletal Radiol"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"R3-20250805","first-page":"278","article-title":"S-Beta Thalassemia leading to avascular necrosis of left hip joint in a young male\u2014a rare case report","volume":"3","author":"Saxena","year":"2016","journal-title":"Int Arch Integrat Med"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/hematology.2019000038","article-title":"Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management","volume":"2019","author":"Adesina","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/bloodadvances.2017005256","article-title":"Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California","volume":"1","author":"Adesina","year":"2017","journal-title":"Blood Adv"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/kew042","article-title":"Haemoglobinopathies and the rheumatologist","volume":"55","author":"Hughes","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00003086-199304000-00018","article-title":"Osteonecrosis of the humeral head in sickle cell disease","volume":"289","author":"Milner","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head","volume":"325","author":"Milner","year":"1991","journal-title":"N Engl J Med"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874325000903010032","article-title":"Multifocal joint osteonecrosis in sickle cell disease","volume":"3","author":"Flouzat-Lachaniete","year":"2009","journal-title":"Open Orthop J"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12178-015-9280-0","article-title":"A current review of core decompression in the treatment of osteonecrosis of the femoral head","volume":"8","author":"Pierce","year":"2015","journal-title":"Curr Rev Musculoskelet Med"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.arth.2013.03.017","article-title":"Excellent results and minimal complications of total hip arthroplasty in sickle cell hemoglobinopathy at mid-term follow-up using cementless prosthetic components","volume":"28","author":"Issa","year":"2013","journal-title":"J Arthroplasty"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/asheducation-2016.1.625","article-title":"Sickle cell disease: when and how to transfuse","volume":"2016","author":"Howard","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.22103","article-title":"Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease","volume":"86","author":"Mahadeo","year":"2011","journal-title":"Am J Hematol"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"e27503","DOI":"10.1002\/pbc.27503","article-title":"Risk of avascular necrosis of the femoral head in children with sickle cell disease on hydroxyurea: MRI evaluation","volume":"66","author":"Adekile","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/ajts.AJTS_128_16","article-title":"Manual red cell exchange transfusion to avert sickle cell related complications","volume":"12","author":"Mehra","year":"2018","journal-title":"Asian J Transfus Sci"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.14383","article-title":"Guidelines on red cell transfusion in sickle cell disease. Part II: indications for transfusion","volume":"176","author":"Davis","year":"2017","journal-title":"Br J Haematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T01:00:58Z","timestamp":1754355658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002155","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"2020-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}